Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -186.63% is 423% below its 5-year average of -35.68%, near the low end of its 5-year range (-186.63%–48.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 190.30% below its 12-month average of -64.29%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -186.63%.
RETURN ON EQUITY (ROE)
-186.63%
RETURN ON EQUITY (ROE) AVG TTM
-64.29%
RETURN ON EQUITY (ROE) AVG 3Y
-28.47%
RETURN ON EQUITY (ROE) AVG 5Y
-35.68%
RETURN ON EQUITY (ROE) AVG 10Y
-36.17%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-190.30%
CURRENT VS 3Y AVG
-555.54%
CURRENT VS 5Y AVG
-423.10%
CURRENT VS 10Y AVG
-415.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
-344.25%
vs the sector median at left
Zymeworks Inc.
Market Cap
$1.89B
Return on Equity (ROE)
-186.63%
TTM Avg
-64.29%
3Y Avg
-28.47%
5Y Avg
-35.68%
Market Cap
$1.89B
Return on Equity (ROE)
12.01%
TTM Avg
-4.52%
3Y Avg
-16.89%
5Y Avg
-11.36%
Market Cap
$1.89B
Return on Equity (ROE)
-40.09%
TTM Avg
4.56%
3Y Avg
-13.84%
5Y Avg
-2.18%
Market Cap
$1.87B
Return on Equity (ROE)
-15.90%
TTM Avg
-35.70%
3Y Avg
-33.44%
5Y Avg
-75.43%
Market Cap
$1.86B
Return on Equity (ROE)
N/A
TTM Avg
-157.29%
3Y Avg
-33.70%
5Y Avg
49.06%
Market Cap
$1.92B
Return on Equity (ROE)
-179.99%
TTM Avg
-188.10%
3Y Avg
28.98%
5Y Avg
-2.67%
Market Cap
$1.85B
Return on Equity (ROE)
-48.43%
TTM Avg
-97.59%
3Y Avg
-126.46%
5Y Avg
-100.04%
Market Cap
$1.94B
Return on Equity (ROE)
-63.45%
TTM Avg
-58.44%
3Y Avg
-22.42%
5Y Avg
15.04%
Market Cap
$1.84B
Return on Equity (ROE)
-28.45%
TTM Avg
-88.46%
3Y Avg
-128.76%
5Y Avg
-100.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zymeworks Inc. (ZYME) | $1.89B | -186.63% | -64.29% | -28.47% | -35.68% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 12.01% | -4.52% | -16.89% | -11.36% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -40.09% | 4.56% | -13.84% | -2.18% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | -15.90% | -35.70% | -33.44% | -75.43% |
| Novavax, Inc. (NVAX)vs › | $1.86B | N/A | -157.29% | -33.70% | 49.06% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | -179.99% | -188.10% | 28.98% | -2.67% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -48.43% | -97.59% | -126.46% | -100.04% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.94B | -63.45% | -58.44% | -22.42% | 15.04% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | -28.45% | -88.46% | -128.76% | -100.86% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 4.88% | 4.47% | 6.79% | 5.89% |
ROE
-186.6%
ROA
-37.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -186.63% |
| 2026-03-31 | -62.75% |
| 2025-12-31 | -30.22% |
| 2025-09-30 | -19.82% |
| 2025-06-30 | -22.03% |
| 2025-03-31 | -34.98% |
| 2024-12-31 | -36.22% |
| 2024-09-30 | -30.97% |
| 2024-06-30 | -27.70% |
| 2024-03-31 | -28.76% |
| 2023-12-31 | -25.53% |
| 2023-09-30 | 48.37% |
| 2023-06-30 | 41.45% |
| 2023-03-31 | 36.45% |
| 2022-12-31 | 25.22% |
| 2022-09-30 | -124.75% |
| 2022-06-30 | -106.61% |
| 2022-03-31 | -84.93% |
| 2021-12-31 | -85.05% |
| 2021-09-30 | -75.50% |
| 2021-06-30 | -69.23% |
| 2021-03-31 | -51.44% |
| 2020-12-31 | -44.05% |
| 2020-09-30 | -49.71% |
| 2020-06-30 | -35.18% |
| 2020-03-31 | -31.19% |
| 2019-12-31 | -59.20% |
| 2019-09-30 | -20.65% |
| 2019-06-30 | -15.63% |
| 2019-03-31 | -17.05% |
| 2018-12-31 | -20.25% |
| 2018-09-30 | -7.72% |
| 2018-06-30 | -5.68% |
| 2018-03-31 | -16.59% |
| 2017-12-31 | -8.94% |
| 2017-09-30 | -65.90% |
| 2017-06-30 | -52.17% |
| 2016-12-31 | -375.57% |
| 2016-09-30 | -38.86% |
